Cat. #162382
Anti-TRAF1 monoclonal antibody [TRAF1-1F3]
Cat. #: 162382
Sub-type: Primary antibody
Target: TRAF1
Class: Monoclonal
Application: WB
Reactivity: Human
Host: Rat
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Helmholtz Munich Core Facility Monoclonal Antibodies
Primary Citation: Siegler et al. 2003. Mol. Pathol. 56: 156-161. PMID: 12782762
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-TRAF1 monoclonal antibody [TRAF1-1F3]
- Alternate name: Anti TRAF1 monoclonal antibody (clone TRAF1-1F3)
- Cancer type: Blood cancer
- Research fields: Cancer;Cell biology;Cell signaling and signal transduction
- Clone: TRAF1-1F3
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Rat
- Disease: Cancer
- Application: WB
- Description: Antibody for TRAF1, also known as Tumor Necrosis Factor Receptor-Associated Factor 1 or TNF receptor (TNFR) associated factor 1. The protein complex formed by this protein and TRAF2 also interacts with inhibitor-of-apoptosis proteins (IAPs), and mediates the anti-apoptotic signals from TNF receptors. TRAF1 has been linked to various cancer types including blood cancer.
- Immunogen: TRAF1-GST fusion protein
- Isotype: IgG2a
Target Details
- Target: TRAF1
- Target alternate names: EB16
- Target background: TRAF1, also known as Tumor Necrosis Factor Receptor-Associated Factor 1 or TNF receptor (TNFR) associated factor 1. The protein complex formed by this protein and TRAF2 also interacts with inhibitor-of-apoptosis proteins (IAPs), and mediates the anti-apoptotic signals from TNF receptors. TRAF1 has been linked to various cancer types including blood cancer.
Applications
- Application: WB
References
- Siegler et al. 2003. Mol. Pathol. 56: 156-161. PMID: 12782762
